- Home
- OMCL vs BXMX Comparison
OMCL vs BXMX Comparison
Compare OMCL & BXMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMCL
- BXMX
- Stock Information
- Founded
- OMCL 1992
- BXMX 2004
- Country
- OMCL United States
- BXMX United States
- Employees
- OMCL N/A
- BXMX N/A
- Industry
- OMCL Computer Manufacturing
- BXMX Investment Managers
- Sector
- OMCL Technology
- BXMX Finance
- Exchange
- OMCL Nasdaq
- BXMX Nasdaq
- Market Cap
- OMCL 1.5B
- BXMX 1.5B
- IPO Year
- OMCL 2001
- BXMX N/A
- Fundamental
- Price
- OMCL $32.11
- BXMX $14.28
- Analyst Decision
- OMCL Buy
- BXMX
- Analyst Count
- OMCL 7
- BXMX 0
- Target Price
- OMCL $46.71
- BXMX N/A
- AVG Volume (30 Days)
- OMCL 549.1K
- BXMX 205.6K
- Earning Date
- OMCL 10-29-2025
- BXMX 01-01-0001
- Dividend Yield
- OMCL N/A
- BXMX 7.24%
- EPS Growth
- OMCL N/A
- BXMX N/A
- EPS
- OMCL 0.49
- BXMX N/A
- Revenue
- OMCL $1,149,529,000.00
- BXMX N/A
- Revenue This Year
- OMCL $5.37
- BXMX N/A
- Revenue Next Year
- OMCL $3.67
- BXMX N/A
- P/E Ratio
- OMCL $67.08
- BXMX N/A
- Revenue Growth
- OMCL 6.39
- BXMX N/A
- 52 Week Low
- OMCL $22.66
- BXMX $11.75
- 52 Week High
- OMCL $55.75
- BXMX $13.75
- Technical
- Relative Strength Index (RSI)
- OMCL 52.90
- BXMX 59.52
- Support Level
- OMCL $31.90
- BXMX $14.07
- Resistance Level
- OMCL $33.75
- BXMX $14.28
- Average True Range (ATR)
- OMCL 0.87
- BXMX 0.12
- MACD
- OMCL -0.10
- BXMX 0.01
- Stochastic Oscillator
- OMCL 31.95
- BXMX 76.94
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
About BXMX Nuveen S&P 500 Buy-Write Income Fund of Beneficial Interest
Nuveen S&P 500 Buy-Write Income Fund is a diversified closed-ended management investment company based in the United States. Its investment objective is to seek attractive total returns with less volatility. The fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500 Index. It also uses an index options strategy of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all-equity portfolio. Its revenue is generated mainly from interest and dividend income.